8-K

0000804753-16-000052.txt : 20160125 0000804753-16-000052.hdr.sgml : 20160125 20160125083016 ACCESSION NUMBER: 0000804753-16-000052 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20160125 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20160125 DATE AS OF CHANGE: 20160125 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CERNER CORP /MO/ CENTRAL INDEX KEY: 0000804753 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373] IRS NUMBER: 431196944 STATE OF INCORPORATION: DE FISCAL YEAR END: 0102 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-15386 FILM NUMBER: 161357554 BUSINESS ADDRESS: STREET 1: 2800 ROCKCREEK PKWY, W0162 STREET 2: ATTN: MARC NAUGHTON CITY: KANSAS CITY STATE: MO ZIP: 64117 BUSINESS PHONE: 8162011024 MAIL ADDRESS: STREET 1: 2800 ROCKCREEK PKWY, W0162 STREET 2: ATTN: MARC NAUGHTON CITY: KANSAS CITY STATE: MO ZIP: 64117 8-K 1 january2016form8k.htm 8-K 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

_______________________________________

FORM 8-K

_______________________________________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 25, 2016

Cerner Corporation

(Exact Name of Registrant as Specified in Its Charter)



Delaware	0-15386		43-1196944
(State or Other Jurisdiction of Incorporation)	(Commission File Number)		(IRS Employer Identification No.)

2800 Rockcreek Parkway, North Kansas City, Missouri		64117
(Address of Principal Executive Offices)		(Zip Code)

(816) 201-1024

(Registrant’s Telephone Number, Including Area Code)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):



¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)



¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)



¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))



¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 7.01 Regulation FD Disclosure.

On January 25, 2016, Neal L. Patterson, Chairman and Chief Executive Officer of Cerner Corporation delivered a note to clients, shareholders and colleagues informing them of a recently diagnosed medical condition. A copy of his note is attached as Exhibit 99.1.

Item 9.01 Financial Statements and Exhibits.

d) Exhibits

99.1 Note from Neal L. Patterson, Chairman and Chief Executive Officer of Cerner Corporation

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



		CERNER CORPORATION

Date: January 25, 2016	By:	/s/ Marc G. Naughton
		Marc G. Naughton, Executive Vice President
		and Chief Financial Officer

EXHIBIT INDEX



Exhibit Number		Description

99.1		Note from Neal L. Patterson, Chairman and Chief Executive Officer of Cerner Corporation

EX-99.1 2 notefromneal.htm EXHIBIT 99.1 Exhibit

Exhibit 99.1

Subject: Personal News

Clients, shareholders and colleagues:

I wanted to let you know that, just after the new year, I was diagnosed with a soft tissue cancer. My physician says the type of cancer I have is treatable and curable, and there is no evidence of cancer elsewhere in my body. I plan to begin treatment immediately.

We have the best leadership team in health care IT, and we are well equipped to continue to manage Cerner with our existing leadership structure while I receive treatment. I plan to stay involved in the business, but with less travel and fewer meetings. In reality, it will not be a big change compared to how we run Cerner day to day already.

It’s not often I’m forced to slow down, but the silver lining will be having some extra ‘think’ time to reflect on all the extraordinary opportunities we have in health IT. After years of studying health care systems around the world, this unique opportunity already has my gears turning.

Balancing transparency and privacy is always a judgment call, but I felt as though I have a duty to communicate. I feel fine, and I’m surrounded by extraordinarily supportive family, friends, Cerner leaders and Board members. Thanks for your support.

Neal